ArticleJACS Au2025

Selective CBP/EP300 Bromodomain Inhibitors: Novel Epigenetic Tools to Counter TNF-α-Driven Inflammation.

Katherine A Gosselé et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.